Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
BMC Cardiovasc Disord ; 20(1): 206, 2020 04 28.
Article in English | MEDLINE | ID: mdl-32345217

ABSTRACT

BACKGROUND: In recent years, the field of cardio-oncology has grown worldwide, bringing benefits to cancer patients in terms of survival and quality of life. This study reports the experience of a pioneer cardio-oncology programme at University Cancer Hospital in Brazil over a period of 10 years, describing the clinical profile of patients and the clinical outcomes. METHODS: A retrospective study was conducted on a cohort of patients treated at the cardio-oncology programme from April 2009 to February 2019. We analysed the characteristics of patients and outcomes, including mortality, according to the type of clinical indication for outpatient care (general cardiology, perioperative evaluation and follow-up and treatment cardiotoxicity). RESULTS: From a total of 26,435 medical consultations, we obtained the data of 4535 individuals among the medical care outpatients. When we analysed the clinical characteristics of patients considering the clinical indication - general cardiology, perioperative evaluation and cardiotoxicity outpatient clinics, differences were observed with respect to age (59 [48-66], 66 [58-74] and 69 [62-76], p < 0.001), diabetes (67 [15%], 635 [22.6%] and 379 [29.8%]; p < 0.001), hypertension (196 [43.8%], 1649 [58.7%] and 890 [70.1%], p < 0.001) and dyslipidaemia (87 [19.7%), 735 [26.2%] and 459 [36.2%], p < 0.001). A similar overall mortality rate was observed in the groups (47.5% vs. 45.7% vs. 44.9% [p = 0.650]). CONCLUSION: The number of oncologic patients in the Cardio-Oncology Programme has grown in the last decade. A well-structured cardio-oncology programme is the key to achieving the true essence of this area, namely, ongoing care for cancer patients throughout the disease treatment process, optimizing their cardiovascular status to ensure they can receive the best therapy against cancer.


Subject(s)
Cancer Survivors , Cardiology , Delivery of Health Care, Integrated , Heart Diseases/therapy , Medical Oncology , Neoplasms/therapy , Radiation Injuries/therapy , Aged , Antineoplastic Agents/adverse effects , Brazil , Cardiotoxicity , Heart Diseases/chemically induced , Heart Diseases/diagnosis , Heart Diseases/mortality , Hospitals, University , Humans , Male , Middle Aged , Neoplasms/mortality , Quality of Life , Radiation Injuries/diagnosis , Radiation Injuries/etiology , Radiation Injuries/mortality , Radiotherapy/adverse effects , Retrospective Studies , Risk Factors , Specialization , Time Factors
2.
J Am Soc Echocardiogr ; 32(9): 1075-1085, 2019 09.
Article in English | MEDLINE | ID: mdl-31235421

ABSTRACT

BACKGROUND: Cardiac shock-wave therapy (CSWT) has been demonstrated as an option for the treatment of patients with refractory angina (RA), promoting immediate vasodilatory effects and, in the long-term, neoangiogenic effects that would be responsible for reducing the myocardial ischemic load. The aim of this study was to determine the effects of CSWT on myocardial blood flow reserve (MBFR) assessed by quantitative real-time myocardial perfusion echocardiography in patients with RA. METHODS: Fifteen patients (mean age 61.5 ± 12.8 years) with RA who underwent CSWT during nine sessions, over 3 months of treatment, were prospectively studied. A total of 32 myocardial segments with ischemia were treated, while another 31 did not receive therapy because of technical limitations. Myocardial perfusion was evaluated at rest and after dipyridamole stress (0.84 mg/kg) before and 6 months after CSWT, using quantitative real-time myocardial perfusion echocardiography. Clinical effects were evaluated using Canadian Cardiovascular Society grading of angina and the Seattle Angina Questionnaire. RESULTS: The ischemic segments treated with CSWT had increased MBFR (from 1.33 ± 0.22 to 1.74 ± 0.29, P < .001), a benefit that was not observed in untreated ischemic segments (1.51 ± 0.29 vs 1.54 ± 0.28, P = .47). Patients demonstrated increased global MBFR (from 1.78 ± 0.54 to 1.89 ± 0.49, P = .017). Semiquantitative single-photon emission computed tomographic analysis of the treated ischemic segments revealed a score reduction from 2.10 ± 0.87 to 1.68 ± 1.19 (P = .024). There was improvement in Canadian Cardiovascular Society score (from 3.20 ± 0.56 to 1.93 ± 0.70, P < .05) and in Seattle Angina Questionnaire score (from 42.3 ± 12.99 to 71.2 ± 14.29, P < .05). No major cardiovascular events were recorded during follow-up. CONCLUSIONS: CSWT improved MBFR in ischemic segments, as demonstrated by quantitative real-time myocardial perfusion echocardiography. These results suggest that CSWT has the potential to increase myocardial blood flow, with an impact on symptoms and quality of life in patients with RA.


Subject(s)
Angina Pectoris/therapy , Coronary Circulation/physiology , Coronary Vessels/diagnostic imaging , Extracorporeal Shockwave Therapy/methods , High-Energy Shock Waves/therapeutic use , Angina Pectoris/diagnosis , Angina Pectoris/physiopathology , Coronary Vessels/physiopathology , Echocardiography , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prospective Studies , Tomography, Emission-Computed, Single-Photon , Treatment Outcome
3.
Echocardiography ; 35(10): 1564-1570, 2018 10.
Article in English | MEDLINE | ID: mdl-29962073

ABSTRACT

BACKGROUND: Cardiac shockwave therapy (CSWT) is a new potential option for the treatment of patients with chronic coronary disease and refractory angina (RA). We aimed to study the effects of CSWT on left ventricular myocardial perfusion and mechanics in patients with RA. METHOD: We prospectively studied 19 patients who underwent CSWT. Left ventricular mechanics were evaluated by speckle tracking echocardiography (STE), and myocardial perfusion by single-photon emission computed tomography, using stress/rest-Technetium-99 m Sestamibi, for determination of summed stress score (SSS). Canadian Cardiac Society (CCS), New York Heart Association (NYHA), and quality of life by Seattle Angina Questionnaire (SAQ) were assessed at baseline and 6 months after therapy. RESULTS: CSWT therapy was applied without major side effects. At baseline, 18 patients (94.7%) had CCS class III or IV, and after CSWT there was reduction to 3 (15.8%), P = .0001, associated with improvement in SAQ (38.5%; P < .001). Thirteen (68.4%) had class NYHA III or IV before treatment, with significant reduction to 7 (36.8%); P = .014. No change was observed in the global SSS from baseline to 6-month follow-up (15.33 ± 8.60 vs 16.60 ± 8.06; P = .157). However, there was a significant reduction in the average SSS of the treated ischemic segments (2.1 ± 0.87 pre vs 1.6 ± 1.19 post CSWT; P = .024). Global longitudinal strain by STE remained unaltered (-13.03 ± 8.96 pre vs -15.88 ± 3.43 6-month post CSWT; P = .256). CONCLUSION: CSWT is a safe procedure for the treatment of patients with RA that results in better quality of life, improvement in myocardial perfusion of the treated segments with preservation of left ventricular mechanics.


Subject(s)
Angina Pectoris/therapy , Echocardiography/methods , Extracorporeal Shockwave Therapy/methods , Heart/physiology , Ventricular Dysfunction, Left/therapy , Angina Pectoris/complications , Angina Pectoris/physiopathology , Female , Heart/diagnostic imaging , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Humans , Male , Middle Aged , Prospective Studies , Radiopharmaceuticals , Technetium Tc 99m Sestamibi , Tomography, Emission-Computed, Single-Photon , Treatment Outcome , Ventricular Dysfunction, Left/complications , Ventricular Dysfunction, Left/physiopathology
4.
Oncotarget ; 8(4): 6994-7002, 2017 Jan 24.
Article in English | MEDLINE | ID: mdl-28052002

ABSTRACT

Cardiotoxicity is associated with the chronic use of doxorubicin leading to cardiomyopathy and heart failure. Identification of cardiotoxicity-specific miRNA biomarkers could provide clinicians with a valuable prognostic tool. The aim of the study was to evaluate circulating levels of miRNAs in breast cancer patients receiving doxorubicin treatment and to correlate with cardiac function. This is an ancillary study from "Carvedilol Effect on Chemotherapy-induced Cardiotoxicity" (CECCY trial), which included 56 female patients (49.9±3.3 years of age) from the placebo arm. Enrolled patients were treated with doxorubicin followed by taxanes. cTnI, LVEF, and miRNAs were measured periodically. Circulating levels of miR-1, -133b, -146a, and -423-5p increased during the treatment whereas miR-208a and -208b were undetectable. cTnI increased from 6.6±0.3 to 46.7±5.5 pg/mL (p<0.001), while overall LVEF tended to decrease from 65.3±0.5 to 63.8±0.9 (p=0.053) over 12 months. Ten patients (17.9%) developed cardiotoxicity showing a decrease in LVEF from 67.2±1.0 to 58.8±2.7 (p=0.005). miR-1 was associated with changes in LVEF (r=-0.531, p<0.001). In a ROC curve analysis miR-1 showed an AUC greater than cTnI to discriminate between patients who did and did not develop cardiotoxicity (AUC = 0.851 and 0.544, p= 0.0016). Our data suggest that circulating miR-1 might be a potential new biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.


Subject(s)
Breast Neoplasms/drug therapy , Cardiotoxicity/genetics , Doxorubicin/adverse effects , MicroRNAs/blood , Biomarkers , Breast Neoplasms/blood , Breast Neoplasms/genetics , Carbazoles , Cardiotoxicity/blood , Cardiotoxicity/physiopathology , Carvedilol , Female , Humans , Middle Aged , Prognosis , Propanolamines , ROC Curve , Stroke Volume/drug effects , Troponin C/metabolism , Ventricular Function, Left/drug effects
6.
Braz. dent. j ; 14(1): 32-36, June 2003. ilus, tab
Article in English | LILACS | ID: lil-340486

ABSTRACT

Copper/aluminum alloys are largely utilized in odontological restorations because they are less expensive than gold or platinum. However, tarnishing and important corrosion in intrabuccal prostheses made with copper/aluminum alloys after 28 days of use have been reported. Several kinds of food and beverage may attack and corrode these alloys. Copper is an essential component of several important enzymes directly involved in mitochondrial respiratory metabolism. Aluminum, in contrast, is very toxic and, when absorbed, plasma values as small as 1.65 to 21.55 µg/dl can cause severe lesions to the nervous system, kidneys, and bone marrow. Because mitochondria are extremely sensitive to minimal variation of cellular physiology, the direct relationship between the mitocondrial respiratory chain and cell lesions has been used as a sensitive parameter to evaluate cellular aggression by external agents. This work consisted in the polarographic study of mitochondrial respiratory metabolism of livers and kidneys of rabbits with femoral implants of titanium or copper/aluminum alloy screws. The experimental results obtained did not show physiological modifications of hepatic or renal mitochondria isolated from animals of the three experimental groups, which indicate good biocompatibility of copper/aluminum alloys and suggest their odontological use


Subject(s)
Animals , Male , Rabbits , Alloys/chemistry , Aluminum/chemistry , Biocompatible Materials/chemistry , Copper/chemistry , Mitochondria/metabolism , Bone Screws , Corrosion , Dental Materials/chemistry , Femur/surgery , Kidney/drug effects , Kidney/metabolism , Mitochondria, Liver/drug effects , Mitochondria, Liver/metabolism , Mitochondria/drug effects , Oxygen Consumption/drug effects , Oxygen Consumption/physiology , Polarography , Statistics as Topic , Surface Properties , Subcellular Fractions/drug effects , Subcellular Fractions/metabolism , Titanium/chemistry
7.
Braz Dent J ; 14(1): 32-6, 2003.
Article in English | MEDLINE | ID: mdl-12656462

ABSTRACT

Copper/aluminum alloys are largely utilized in odontological restorations because they are less expensive than gold or platinum. However, tarnishing and important corrosion in intrabuccal prostheses made with copper/aluminum alloys after 28 days of use have been reported. Several kinds of food and beverage may attack and corrode these alloys. Copper is an essential component of several important enzymes directly involved in mitochondrial respiratory metabolism. Aluminum, in contrast, is very toxic and, when absorbed, plasma values as small as 1.65 to 21.55 microg/dl can cause severe lesions to the nervous system, kidneys, and bone marrow. Because mitochondria are extremely sensitive to minimal variation of cellular physiology, the direct relationship between the mitocondrial respiratory chain and cell lesions has been used as a sensitive parameter to evaluate cellular aggression by external agents. This work consisted in the polarographic study of mitochondrial respiratory metabolism of livers and kidneys of rabbits with femoral implants of titanium or copper/aluminum alloy screws. The experimental results obtained did not show physiological modifications of hepatic or renal mitochondria isolated from animals of the three experimental groups, which indicate good biocompatibility of copper/ aluminum alloys and suggest their odontological use.


Subject(s)
Alloys/chemistry , Aluminum/chemistry , Biocompatible Materials/chemistry , Copper/chemistry , Mitochondria/metabolism , Animals , Bone Screws , Corrosion , Dental Materials/chemistry , Femur/surgery , Kidney/drug effects , Kidney/metabolism , Male , Mitochondria/drug effects , Mitochondria, Liver/drug effects , Mitochondria, Liver/metabolism , Oxygen Consumption/drug effects , Oxygen Consumption/physiology , Polarography , Rabbits , Statistics as Topic , Subcellular Fractions/drug effects , Subcellular Fractions/metabolism , Surface Properties , Titanium/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...